A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors
NCT02759666
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasm
Solid Tumors
Interventions
DRUG:
SHR3162
Sponsor
Atridia Pty Ltd.